George Cardoza, President, Pharma Services at NEOGENOMICS INC (NEO), sold 260,000 shares at $45.19 ($11.8M) on 2020-11-24, disclosed to the SEC on 2020-11-25.
Open-market sale of $11.8M NEO by President, Pharma Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.19 | 52,926 | $2.4M | 20.3% |
| 2 | $45.19 | 52,926 | $2.4M | 20.3% |
| 3 | $45.48 | 77,074 | $3.5M | 29.7% |
| 4 | $45.48 | 77,074 | $3.5M | 29.7% |
| Total | $45.36 avg | 260,000 | $11.8M | 100% |
| Filing → |
| SOPH | BUY | 2026-06-05 | $99K | — | Filing → |
| SOPH | SELL | 2026-04-10 | $7K | — | Filing → |
| SOPH | SELL | 2026-04-08 | $24K | — | Filing → |